Daily Stock Market News

Why U.S. Marijuana Stocks Like Curaleaf Rose Today

What happened

The stock market as a whole had a very good session Monday, but marijuana stocks had an excellent one. Some shot as high as the double digits in terms of percentage gain on the day while trouncing the S&P 500‘s gain. 

Among Monday’s winners were prominent U.S.-based multistate operators (MSOs) Curaleaf Holdings (OTC:CURLF) and Green Thumb Industries (OTC:GTBIF), which rose a respective 3% and 3.5%. Meanwhile a frequent laggard in the sector, cannabidiol (CBD) specialist Charlotte’s Web Holdings (OTC:CWBHF), was a surprise double-digit gainer, with an outsized 14% rise on the day.

Female marijuana professional pinching a marijuana plant.

Image source: Getty Images.

So what

Despite the big stock market rally we witnessed on Monday, many investors and pundits believe that numerous sectors — hello, tech! — are vastly overvalued. As a result, people are looking for bargains, and the beleaguered marijuana sector certainly fits the bill.

Those bargain-hunters were also likely encouraged by a pair of not-necessarily major developments. The first was an article in pot industry news/analysis website MJBizDaily.com. This pointed out that the push to decriminalize or fully legalize marijuana in the U.S. is uniting politicians and lobbyists from various points on the political spectrum. 

Another development is occurring in Virginia, where legistlators are introducing new bills to change the recreational marijuana law passed in 2021. Among other positive measures, these bills would open the recreational market sooner than the 2024 start enshrined in the law, and cut the overall tax rate on such products to 10% from 21%.

Now what

Taken separately, neither of these items is particularly impactful to U.S. pot stocks, although Green Thumb is a bit of an exception as it is already an operator of dispensaries in Virginia. Rather, both are indicative of the widespread, top-to-bottom support cannabis law reform enjoys in this country.

Later, rather than sooner, all types of marijuana consumption and sale will be at least de facto legal in this country. And nearly every weed company, particularly those already well entrenched in the U.S. market, should benefit commensurately.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.

Read More: Why U.S. Marijuana Stocks Like Curaleaf Rose Today

You might also like
A note to our visitors

This website has updated its privacy policy in compliance with changes to European Union data protection law, for all members globally. We’ve also updated our Privacy Policy to give you more information about your rights and responsibilities with respect to your privacy and personal information. Please read this to review the updates about which cookies we use and what information we collect on our site. By continuing to use this site, you are agreeing to our updated privacy policy.